Malawi’s Ministry of Health Takeover of Advanced HIV Disease Care Linked to Lower Mortality

A phased handover of advanced HIV disease (AHD) services from external partners to Malawi’s Ministry of Health was associated with a significant drop in patient deaths, according to a retrospective cohort evaluation conducted across 22 health facilities in the country’s Central Region. The study compared outcomes before and after the transition, finding that twelve-month mortality fell from 9.4 percent among patients enrolled pre-transition to 5.5 percent after the Ministry assumed full leadership, an adjusted hazard ratio of 0.59 (95 percent confidence interval 0.37 to 0.94, p = 0.026). Retention in care remained statistically stable over the same period.

The transition was designed to promote sustainability and strengthen national ownership of AHD programs, shifting responsibility for key service elements from partner-led implementation to government leadership. The evaluation covered two enrollment windows: a pre-transition period from January 2020 to December 2021 and a post-transition period from January 2023 to December 2024. Patients qualified under national AHD criteria, which include a CD4 count below 200 cells/mm³, WHO clinical stage 3 or 4 disease, or age under five years. Data were abstracted from clinical records and routine facility registers, yielding a cohort of 1,044 AHD clients, 553 enrolled before the handover and 491 after.

The analysis applied Kaplan–Meier curves, Cox proportional hazards models, and Fine and Gray competing risk models to assess six- and twelve-month mortality and retention as primary outcomes. Beyond survival, the researchers tracked diagnostic coverage and uptake of tuberculosis preventive therapy (TPT), two pillars of AHD care. The results were mixed on these program indicators. CD4 testing uptake declined sharply, from 80.7 percent pre-transition to 46.0 percent post-transition (p < 0.001), while WHO clinical staging and TB diagnostic coverage improved over the same intervals. Documented TB diagnoses fell from 44.5 percent to 31.2 percent (p = 0.002), and TPT uptake dropped from 46.4 percent to 31.6 percent (p < 0.001).

Demographic shifts accompanied the service changes. The median age of enrolled patients rose from 35.9 to 38.5 years across the two periods, a difference the authors report as statistically significant (p < 0.001). The study population spanned children and adults, with eligibility driven by the severity-based national criteria rather than a fixed age band, so the aging cohort reflects who entered AHD care in each window rather than a change in program eligibility.

The authors are careful about what the design can and cannot show. Because the evaluation compared pre- and post-implementation periods rather than randomizing facilities or patients, the pre-transition versus post-transition comparison precludes causal attribution; the mortality decline is an association observed alongside the handover, not proof that the transition itself caused fewer deaths. The authors note that continued mentorship and government ownership appeared to support the outcomes, and that the findings broadly favor sustained domestic management of AHD services in this setting.

The indicator declines carry their own weight in the findings. Lower CD4 testing uptake matters because CD4 measurement drives AHD classification and triggers access to targeted interventions for patients with advanced immunosuppression. Reduced TPT uptake similarly leaves a preventive gap, since tuberculosis remains a leading cause of death among people with advanced HIV disease. The drop in recorded TB diagnoses, set against improved TB diagnostic coverage, may reflect changes in screening intensity, documentation, or the underlying case mix of enrollees, and the study does not disentangle these possibilities.

As a retrospective cohort drawn from 22 facilities in Central Malawi, the evaluation’s scope is geographically bounded and dependent on the completeness of routine registers and clinical records. Mortality ascertainment within program data may miss deaths occurring outside facility contact, a common limitation of cohort studies based on care records. The two enrollment windows also bracket a period of broader health system disruption, including the COVID-19 pandemic, which the design cannot separate from the effects of the handover itself.

Within those limits, the study offers a rare quantitative look at what happens when donor-supported HIV services are returned to national management, a question of pressing importance as funding landscapes shift across high-burden countries. The combination of falling mortality and stable retention, alongside measurable declines in CD4 testing and TPT uptake, suggests that Malawi’s transition preserved core survival outcomes while leaving specific diagnostic and preventive components in need of reinforcement. The authors frame continued mentorship as part of the pathway supporting these results, and identify the service gaps as priorities for strengthening as government ownership matures.

Subject of Research: Impact of a phased transition model on Advanced HIV Disease outcomes: A pre- and post-implementation evaluation study in Malawi

Article Title: Impact of a phased transition model on Advanced HIV Disease outcomes: A pre- and post-implementation evaluation study in Malawi

Article References: Maphosa, T., Machekano, R., Ndam, L. D., Makonokaya, L., Chilikutali, L., Kalitera, L. U., Matiya, E., Mayi, A., Musarandega, R., Matola, B. W., Berhan, A. Y., Ahimbisibwe, A., & Tiam, A. (2026). Impact of a phased transition model on Advanced HIV Disease outcomes: A pre- and post-implementation evaluation study in Malawi. PLOS Global Public Health, 6(10), e0006348. https://doi.org/10.1371/journal.pgph.0006348

Image Credits: AI Generated

DOI: 10.1371/journal.pgph.0006348

Keywords: Impact, phased, transition, model, Advanced, Disease, outcomes, pre-, post-implementation, evaluation, Malawi, scientific research